BRIEF-Novartis – study confirms etanercept has equivalent efficacy to originator

* Says innovative study with three treatment switches confirms sandoz biosimilar etanercept has equivalent efficacy to originator Source text for Eikon: Further company coverage: (Reporting By Zu…
Read the full story: Reuters: Healthcare